BCM
IOVA icon

Brookstone Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History

Brookstone Capital Management’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$79.5K Sell
22,662
-21
-0.1% -$67 ﹤0.01% 1185
2025
Q4 		$61.9K Sell
22,683
-238
-1% -$551 ﹤0.01% 1152
2025
Q3 		$49.7K Buy
22,921
+10
+0% +$24 ﹤0.01% 1125
2025
Q2 		$39.4K Sell
22,911
-16
-0.1% -$40 ﹤0.01% 1053
2025
Q1 		$76.3K Buy
22,927
+2,344
+11% +$12.1K ﹤0.01% 1000
2024
Q4 		$152K Buy
20,583
+528
+3% +$4.89K ﹤0.01% 963
2024
Q3 		$188K Buy
20,055
+6,120
+44% +$58K ﹤0.01% 971
2024
Q2 		$125K Buy
+13,935
New +$149K ﹤0.01% 931

Other funds holding IOVA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.17B AUM 0.03% 1-Year Est. Return